Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

Melanoma

"Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: Clinical application to boron neutron capture therapy for head and neck cancer" (2017) González, S.J.;Pozzi, E.C.C.;Monti Hughes, A. (...)Schwint, A.E. Physics in Medicine and Biology. 62(20):7938-7958

"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808

"Combined local and systemic bleomycin administration in electrochemotherapy to reduce the number of treatment sessions" (2016) Maglietti, F.;Tellado, M.;Olaiz, N. (...)Marshall, G. Radiology and Oncology. 50(1):58-63

"Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated" (2016) Bracalente, C.;Ibañez, I.L.;Berenstein, A. (...)Durán, H. Oncotarget. 7(27):41154-41171

"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281

"Human MageB2 protein expression enhances E2F transcriptional activity, cell proliferation, and resistance to ribotoxic stress" (2015) Peche, L.Y.;Ladelfa, M.F.;Toledo, M.F. (...)Monte, M. Journal of Biological Chemistry. 290(49):29652-29662

"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274

"Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference" (2014) Croci, D.O.; Rabinovich, G.A. OncoImmunology. 3(6)

"CD207+ cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice" (2014) Ruiz, M.S.;Mac Keon, S.;Campisano, S. (...)Wainstok, R. Vaccine. 32(11):1229-1232

"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290

"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262

"Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine" (2013) Tapia, I.J.;Aris, M.;Arriaga, J.M. (...)Barrio, M.M. Cryobiology. 67(2):163-169

"Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors" (2013) Campisano, S.;Mac Keon, S.;Gazzaniga, S. (...)Wainstok, R. Vaccine. 31(2):354-361

"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17

"Human Natural Killer Cell Maturation Defect Supports In Vivo CD56bright to CD56dim Lineage Development" (2012) Domaica, C.I.;Fuertes, M.B.;Uriarte, I. (...)Zwirner, N.W. PLoS ONE. 7(12)

"Premalignant quiescent melanocytic nevi do not express the MHC class i chain-related protein A " (2011) Fuertes, M.B.;Rossi, L.E.;Peralta, C.M. (...)Zwirner, N.W. Medicina. 71(4):357-360

"Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from laminaria saccharina brown seaweed" (2011) Croci, D.O.;Cumashi, A.;Ushakova, N.A. (...)Nifantiev, N.E. PLoS ONE. 6(2)

"c-Jun regulates phosphoinositide-dependent kinase 1 transcription: Implication for Akt and protein kinase C activities melanoma tumorigenesis" (2010) Lopez-Bergami, P.;Kim, H.;Dewing, A. (...)Ronai, Z. Journal of Biological Chemistry. 285(2):903-913

"Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue" (2010) Keon, S.M.;Gazzaniga, S.;Mallerman, J. (...)Wainstok, R. Vaccine. 28(51):8162-8168

"Characterization of border structure using Fractal Dimension in melanomas" (2010) Carbonetto, S.H.; Lew, S.E. 2010 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC'10:4088-4091

"Dynamic infrared imaging of cutaneous melanoma and normal skin in patients treated with BNCT" (2009) Santa Cruz, G.A.;Bertotti, J.;Marín, J. (...)Liberman, S.J. Applied Radiation and Isotopes. 67(7-8 SUPPL):S54-S58

"Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas" (2009) Labeur, M.; Paez-Pereda, M.; Arzt, E.; Stalla, G.K. Reviews in Endocrine and Metabolic Disorders. 10(2):103-109

"Tumor control and normal tissue complications in BNCT treatment of nodular melanoma: A search for predictive quantities" (2009) González, S.J.;Casal, M.;Pereira, M.D. (...)Liberman, S.J. Applied Radiation and Isotopes. 67(7-8SUPPL):S153-S156

"A computational dosimetry tool for the study of tumor doses and skin toxicities in BNCT" (2009) Gossio, S.; Carando, D.G.; González, S.J. Applied Radiation and Isotopes. 67(7-8 SUPPL):S145-S148

"Induction and Rejoining of DNA Double Strand Breaks Assessed by H2AX Phosphorylation in Melanoma Cells Irradiated with Proton and Lithium Beams" (2009) Ibañez, I.L.;Bracalente, C.;Molinari, B.L. (...)Durán, H. International Journal of Radiation Oncology Biology Physics. 74(4):1226-1235

"A general tumour control probability model for non-uniform dose distributions" (2008) González, S.J.; Carando, D.G. Mathematical Medicine and Biology. 25(2):171-184

"A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predictor of disease progression" (2008) von Euw, E.M.;Barrio, M.M.;Furman, D. (...)Mordoh, J. Journal of Translational Medicine. 6

"Monocyte-derived dendritic cells loaded with a mixture of apoptotic/ necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes" (2007) von Euw, E.M.;Barrio, M.M.;Furman, D. (...)Mordoh, J. Journal of Translational Medicine. 5

"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft" (2007) Gazzaniga, S.;Bravo, A.I.;Guglielmotti, A. (...)Wainstok, R. Journal of Investigative Dermatology. 127(8):2031-2041

"Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells" (2007) Sosa, M.S.;Girotti, M.R.;Salvatierra, E. (...)Llera, A.S. Proteomics. 7(22):4123-4134

"Monocyte chemoattractant protein correlates with angiogenesis in metastatic melanoma " (2006) Gazzaniga, S.; Bravo, A.I.; Mordoh, J.; Wainstok, R. Acta Bioquimica Clinica Latinoamericana. 40(4):463-467

"Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids" (2004) Finocchiaro, L.M.E.;Bumaschny, V.F.;Karara, A.L. (...)Glikin, G.C. Cancer Gene Therapy. 11(5):333-345

"Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases" (2002) Morvillo, V.;Lüthy, I.A.;Bravo, A.I. (...)Mordoh, J. Melanoma Research. 12(6):529-538

"Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice" (2001) Gazzaniga, S.;Bravo, A.;Goldszmid, S.R. (...)Wainstok, R. Journal of Investigative Dermatology. 116(5):664-671

"Metastatic melanoma within the internal auditory canal: A case report" (1999) Cervio, A.;Saadia, D.;Nogués, M. (...)Coppola, F. American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 20(4):263-265

"Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells" (1997) Fernanda Ledda, M.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Nature Medicine. 3(2):171-176

"Role of Melanin as a Scavenger of Active Oxygen Species" (1993) BUSTAMANTE, J.; BREDESTON, L.; MALANGA, G.; MORDOH, J. Pigment Cell Research. 6(5):348-353

"Melanin content and hydroperoxide metabolism in human melanoma cells" (1991) Bustamante, J.;Guerra, L.;Bredeston, L. (...)Boveris, A. Experimental Cell Research. 196(2):172-176

"Differentiating effect of l-tyrosine on the human melanoma cell line IIB-MEL-J" (1990) Guerra, L.; Bover, L.; Mordoh, J. Experimental Cell Research. 188(1):61-65

"Characterization of IIB‐MEL‐J: A New and Highly Heterogenous Human Melanoma Cell Line" (1989) GUERRA, L.;MORDOH, J.;SLAVUTSKY, I. (...)MEDRANO, E.E. Pigment Cell Research. 2(6):504-509

"Suppressor activity induced by Concanavalin A in peripheral lymphocytes from patients with solid malignant tumors " (1983) Garcia, M.S.; Baranao, R.I.; Fernandez, O.; Rumi, L.S. Acta Physiologica Latino-Americana. 33(1):19-24